The long term investor will need a strong stomach, no scardy cats. The biotech investors will not like waiting till Dec 2012 for good results, if any. I have a bad feeling the share price will go below a dollar in the 1st half of 2012.
Here's a few things that may keep the share price above a dollar.
There is a chance of a buy-out or partership with a company with deep pockets.
The brain treatment for cancer GRN1005, results 1st quarter of 2013
The four Phase II trials that end Dec 2012 and results will be in same month.
Good luck in this rigged casino,
No comments:
Post a Comment